Health Condition 1: F411- Generalized anxiety disorder
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex between the age of 20 60 years, Fulfilling DSM V diagnostic criteria for GAD and willing to participate in the study and having any sign and symptoms of Generalized Anxiety Disorder and Vishada will be included in the study.
Exclusion criteria
Exclusion criteria: Patients with symptoms of co-morbid psychiatric disorders, on psychotropic drugs, doing substance abuse like alcohol, tobacco , opium etc. and who having significant depression and other medical serious systemic diseases like cancer, tuberculosis etc and uncontrolled Hypertension, Diabetes Mellitus and dyslipidemia will be excluded in the study. Pregnant and lactating women will be excluded from the study. Having history of hypersensitivity or allergy to study drugs, Severe renal impairment (eGFR less than 30 mL/min/1.73 m ),Hepatic impairment (aspartate aminotransferase or alanine aminotransferase more than 2 times the upper limit of normal), Uncontrolled hypertension (systolic blood pressure more than 180 mmHg or diastolic blood pressure more than 100 mmHg)and Presence of any other serious medical condition that may interfere with study participation will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be the Change in Hamilton s anxiety rating scale.Timepoint: From Base line(0th day)to 28th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Pittsburgh Sleep Quality Index (PSQI) Change in Serum Cortisol level Change in symptoms of Vishada.Timepoint: From Base line(0th day)to 28th day | — |
Countries
India
Contacts
National Institute of Ayurveda , Deemed to be University , Jaipur , Rajasthan